Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation Combined With Unrelated Cord Blood for Patients With Hematologic Malignancies: A Prospective, Phase II Study

Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-018-0382-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Two Dose Levels of Rabbit Antithymocyte Globulin as Graft-Versus-Host Disease Prophylaxis in Haploidentical Stem Cell Transplantation: A Multicenter Randomized Study

BMC Medicine
Medicine
2019English

Beneficial Impact of Low-Dose Rabbit Anti-Thymocyte Globulin in Unrelated Hematopoietic Stem Cell Transplantation: Focusing on Difference Between Stem Cell Sources

Bone Marrow Transplantation
TransplantationHematology
2018English

Low Incidence of Chronic GVHD After HLA-haploidentical Peripheral Blood Stem Cell Transplantation With Post-Transplantation Cyclophosphamide in Older Patients

British Journal of Haematology
Hematology
2016English

Calcineurin Inhibitor–Free Graft-Versus-Host Disease Prophylaxis With Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Infectious Complications After Post‐transplantation Cyclophosphamide and Anti‐thymocyte Globulin‐based Haploidentical Stem Cell Transplantation

British Journal of Haematology
Hematology
2019English

A Phase I Dose Escalation Study of High-Dose Thiotepa, Melphalan and Carboplatin (TMCb) Followed by Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients With Solid Tumors and Hematologic Malignancies

Bone Marrow Transplantation
TransplantationHematology
2000English

Double-Unit Cord Blood Transplantation After Myeloablative Conditioning for Patients With Hematologic Malignancies: A Multicenter Phase II Study in Japan

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Haploidentical Hematopoietic Stem Cell Transplantation in Children With High Risk Hematologic Malignancies: Outcomes With Two Different Strategies for Graft-Versus-Host-Disease Prevention: Ex Vivo T-Cell Depletion and Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Tacrolimus for Prevention of Graft-Versus-Host Disease After Mismatched Unrelated Donor Cord Blood Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy